A randomized trial of olaparib, durvalumab, and cancer vaccine, UV1, as maintenance therapy in patients with BRCAwt with recurrent ovarian cancer: ENGOT-OV56/NSGO-CTU-DOVACC trial.
| Autor: | Mirza, Mansoor Raza, Pietzner, Klaus, Van Nieuwenhuysen, Els, Marth, Christian, Boere, Ingrid, Lindemann, Kristina, Fernebro, Josefin, Hietanen, Sakari, Brasiuniene, Birute, Pors, Kirsten, Gybel Frederiksen, Signe, Ji Mee Willerslev, Ulrikke, Braicu, Elena Ioana, Madsen, Kristine, Zagouri, Flora |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS5615-TPS5615, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|